新冠居家令期间1型糖尿病行为改变与血糖控制改善
研究基于法国CoviDIAB网络应用,对1378名1型糖尿病患者进行观察性问卷调查,比较封锁前2个月与封锁后1个月的平均血糖。结果显示平均血糖从9.1±1.7 mmol/L降至8.7±1.7 mmol/L(P<0.001),减少饮酒、增加扫描频率等行为与更好血糖控制相关。
要点
- 居家令期间1型糖尿病患者平均血糖从9.1降至8.7 mmol/L。
- 减少饮酒、增加FGM扫描频率与更好血糖控制相关。
- 低血糖事件增多和控糖感知更容易也与血糖改善相关。
核心结论
- 居家令对1型糖尿病患者的血糖控制有积极影响。
研究设计与样本
- 观察性评估,基于法国全国性网络应用CoviDIAB的自我报告问卷,纳入1378名使用FGM的1型糖尿病患者。
主要发现
- 平均血糖从封锁前2个月的9.1±1.7 mmol/L改善至封锁后1个月的8.7±1.7 mmol/L(P<0.001)。
- 减少饮酒与更好血糖控制相关(OR 1.75,95%CI 1.04-2.94)。
- 增加FGM扫描频率与更好血糖控制相关(OR 1.48,95%CI 1.04-2.10)。
- 低血糖事件增多与更好血糖控制相关(OR 1.67,95%CI 1.13-2.46)。
- 控糖感知更容易与更好血糖控制相关(OR 1.71,95%CI 1.18-2.49)。
临床怎么用
- 在类似居家限制期间,可鼓励1型糖尿病患者减少饮酒并增加FGM扫描频率以改善血糖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of coronavirus disease 2019 lockdown on glycemic control and associated factors in people living with type 1 diabetes. RESEARCH DESIGN AND METHODS: An observational evaluation from a self-reported questionnaire on behavioral changes and glycemic information from flash glucose monitoring (FGM) during the lockdown in 1,378 individuals living with type 1 diabetes who used a French dedicated nationwide web application (CoviDIAB). RESULTS: The main outcome was the change of the mean glucose level 2 months before and 1 month after the lockdown. We found that mean glucose improved from 9.1 ± 1.7 mmol/L to 8.7 ± 1.7 mmol/L (P < 0.001). Factors associated with better glycemic control were a decrease of alcohol consumption (odds ratio [OR] 1.75 [95% CI 1.04-2.94]), an increase in the frequency of FGM scans (OR 1.48 [1.04-2.10]) and in the number of hypoglycemia events (OR 1.67 [1.13-2.46]), and an easier diabetes control perception (OR 1.71 [1.18-2.49]). CONCLUSIONS: Our findings suggest that lockdown has a positive impact on glycemic control in people with type 1 diabetes.
引用
- Potier L, Hansel B, Larger E, et al. Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes. Diabetes Care. 2020. PMID: 33361146. doi:10.2337/dc20-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。